Industry NewsViiV Healthcare announces FDA approval of the first complete long-acting regimen for HIV treatment
Industry NewsSherlock Biosciences announces discovery of novel CRISPR-Cas enzymes, enabling simple multiplex diagnostic solutions
Industry NewsXBiotech candidate True Human™ COVID-19 therapy found to target highly infectious emerging strain
Industry NewsSyntekabio, Hanmi Science collaborate to develop COVID-19 treatments using drug repurposing technologies
Industry NewsUniversity of Bern establishes a multidisciplinary center for research into infectious diseases and immunity
Industry NewsAntibiotic Research UK welcomes INEOS Oxford Institute to combat antimicrobial resistance as an important step forward
Product NewsMission Bio launches single-cell multi-omics system for faster development of precision cancer therapies
Expert InsightsUrinary NMR diagnostics for inborn errors of metabolism using rule-based interpretation (for research use only)
Industry NewsPfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize coronavirus mutations
Industry NewsCOVID-19 therapeutic treatment is world's first synthetic biological drug to receive FDA approval for phase III trials
Expert InsightsExpand your laboratory capabilities with the Agilent StreamSelect LC/MS system: Your questions answered
Industry NewsAbivax’s COVID-19 phase 2b/3 trial with ABX464 declared research national priority by the French government’s clinical trial council
Industry NewsSygnature Discovery invests £3m to expand high-throughput screening and translational oncology capabilities
